Effects of sildenafil and tadalafil on ischemia/reperfusion injury in fetal rat brain

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 2, 2011, Pages 317-323

  Ozdegirmenci, Ozlem ^a   Kucukozkan, Tuncay ^a   Akdag, Elvin ^b   Topal, Turgut ^b   Haberal, Ali ^a   Kayir, Hakan ^b   Oter, Sukru ^b   Akyol, Mesut ^b   Uzbay, Tayfun ^b  

^a Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Ischemia reperfusion; oxidative injury; rat(s); sildenafil; tadalafil

Indexed keywords

GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SILDENAFIL; SUPEROXIDE DISMUTASE; TADALAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; ARTICLE; BRAIN ISCHEMIA; BRAIN LEVEL; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVITY; FEMALE; FETUS; FETUS HYPOXIA; FETUS WEIGHT; LIPID PEROXIDATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SPECTROPHOTOMETRY; WEIGHT CHANGE;

ANIMALS; BRAIN; CARBOLINES; FEMALE; FETUS; GLUTATHIONE PEROXIDASE; MALONDIALDEHYDE; PIPERAZINES; PREGNANCY; PURINES; RANDOM ALLOCATION; RATS; RATS, WISTAR; REPERFUSION INJURY; SULFONES; SUPEROXIDE DISMUTASE; VASODILATOR AGENTS;

EID: 78651425799     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.492061     Document Type: Article

References (31)

1. Jensen A, Garnier Y, Middlelonis J, Berger R. Perinatal brain damage - from pathophysiology to prevention. Eur J Obstet Gynecol Reprod Biol 2003;110:S70-S79. (Pubitemid 37072143)
2. Hankins GDV, Speer M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol 2003;102:628-636. (Pubitemid 37311232)
3. Von Bel F, Groenendaal F. Long-term pharmacologic neuroprotection after birth asphyxia:where do we stand? Neonatology 2008;94:203-210.
4. Nedeljkovic ZS, Gokce N, Loscalzo J. Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J 2003;79:195-200. (Pubitemid 36605780)
5. Förstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 2008;5:338-349. (Pubitemid 351761708)
6. Kass DA, Takimoto E, Nagayama T, Champion HC. Phosphodiesterase regulation of nitric oxide signaling. Cardiovasc Res 2007;75:303-314. (Pubitemid 46961917)
7. Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG. Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur Urol 2006;50:1194-1207. (Pubitemid 44692918)
8. Farooq MU, Naravetla B, Moore PW, Majid A, Gupta R, Kassab MY. Role of sildenafil in neurological disorders. Clin Neuropharmacol 2008;31:353-362.
9. Wright PJ. Comparison of phosphodiesterase type 5 (PDE5) inhibitors. Int J Clin Pract 2006;60:967-975. (Pubitemid 44082288)
10. Zhang R, Zhang L, Zhang Z, Wang Y, Lu M, Lapointe M, Chopp M. A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats. Ann Neurol 2001;50:602-611. (Pubitemid 33021918)
11. Atalay B, Caner H, Cekinmez M, Ozen O, Celasun B, Altinors N. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 2006;59:1102-1107. (Pubitemid 44852120)
12. Zhang L, Zhang Z, Zhang RL, CuiY, LaPointe MC, Silver B, Chopp M. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke. Brain Res 2006;1118: 192-198. (Pubitemid 44633866)
13. Irkorucu O, Tascilar O, Cakmak GK, Karakaya K, Emre AU, Ucan BH, Bahadir B, Acikgoz S, Ankarali H, Ugurbas E, et al. The effect of sildenafil on an animal model for ischemic colitis. Dig Dis Sci 2008;53:1618-1623. (Pubitemid 351624418)
14. Hascalik S, Celik O, Turkoz Y, Mizrak B. Clip Turcica: a new apparatus for experimental ovarian ischemia and reperfusion model in rats. Fertil Steril 2005;84:219-220. (Pubitemid 40991484)
15. Wakatsuki A, Okatani Y, Izumiya C, Ikenove N. Effects of ischemia-reperfusion on xanthine oxidase activity in fetal rat brain capillaries. Am J Obstet Gynecol 1999;181:731-735. (Pubitemid 29453540)
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin-phenol reagent. J Biol Chem 1951;193:265-275.
17. Okhawa H, Ohshi N, Yagi K. Assay or lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358. (Pubitemid 9194347)
18. Sun Y, Oberley LW, Ying L. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
19. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
20. Perlman JM. Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Clin Ther 2006;28:1353-1365. (Pubitemid 44740075)
21. Uthayathas S, Karuppagounder SS, Thrash BM, Parameshwaran K, Suppiramaniam V, Dhanasekaran M. Versatile effects of sildenafil: recent pharmacological applications. Pharmacol Rep 2007;59:150-163. (Pubitemid 46952406)
22. Kukreja RC, Salloum F, Das A, Ockaili R, Yin C, Bremer YA, Fisher PW, Wittkamp M, Hawkins J, Chou E, et al. Pharmacological preconditioning with sildenafil: basic mechanisms and clinical implications. Vascul Pharmacol 2005; 42:219-232. (Pubitemid 40726325)
23. Schwarz ER, Kapur V, Rodriquez J, Rastoqi S, Rosanio S. The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems. Int J Impot Res 2007;19:139-148. (Pubitemid 46340828)
24. Tawakol A, Aziz K, Migrino R, Watkowska J, Zusman R, Alpert NM, Fischman AJ, Gewirtz H. Effects of sildenafil on myocardial blood flow in humans with ischemic heart disease. Coron Artery Dis 2005;16:443-449. (Pubitemid 41527452)
25. Irkorucu O, Ucan BH, Cakmak GK, Emre AU, Tascilar O, Ofluoglu E, Bahadir B, Karakaya K, Demirtas C, Ankarali H, et al. Does sildenafil reverse the adverse effects of ischemia on ischemic colon anastomosis: yes, no. Int J Surg 2009; 7:39-43.
26. Beheshtian A, Salmasi AH, Payabvash S, Kiumehr S, Ghazinezami B, Rahimpour S, Tavangar SM, Dehpour AR. Protective effects of sildenafil administration on testicular torsion/detorsion damage in rats. World J Urol 2008;26:197-202.
27. Kiymaz N, Yilmaz N, Mumcu C, Anlar O, Ozen S, Kayaoǧlu CR. Protective effect of sildenafil (Viagra) in transient spinal cord ischemia. Pediatr Neurosurg 2008;44:22-28. (Pubitemid 350308360)
28. Sánchez-Aparicio P, Mota-Rojas D, Nava-Ocampo AA, Trujillo-Ortega ME, Alfaro-Rodríguez A, Arch E, Alonso-Spilsbury M. Effects of sildenafil on the fetal growth of guinea pigs and their ability to survive induced intrapartum asphyxia. Am J Obstet Gynecol 2008;198:127.e1-127.e6.
29. Villanueva-García D, Mota-Rojas D, Hernández- González R, Sánchez-Aparicio P, Alonso-Spilsbury M, Trujillo-Ortega ME, Necoechea RR, Nava-Ocampo AA. A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour. J Obstet Gynaecol 2007;27:255-259. (Pubitemid 46676394)
30. Refuerzo JS, Sokol RJ, Aranda JV, Hallak M, Hotra JW, Kruger M, Sorokin Y. Sildenafil citrate and fetal outcome in pregnant rats. Fetal Diagn Ther 2006;21:259-263.
31. Miller SL, Loose JM, Jenkin G, Wallace EM. The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus. Am J Obstet Gynecol 2009;200:102.e1-102.e7.